NCT03309800View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

March 29, 2017

Primary Completion Date

August 17, 2017

Study Completion Date

August 28, 2017

Conditions
Acute Bronchitis
Interventions
DRUG

HL301

HL301: 2Tab/day: 1 Tablet at once, 2 times a day, 7 days of treatment

DRUG

HL301(Placebo)

HL301(Placebo): 2Tab/day: 1 Tablet at once, 2 times a day, 7 days of treatment

Trial Locations (1)

130-872

Kyung Hee University Hospital, Seoul

All Listed Sponsors
lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT03309800 - A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients | Biotech Hunter | Biotech Hunter